The mechanism of action of the fungicidal peptide auristatin PHE was investigated in Cryptococcus neoformans. Since auristatin PHE causes budding arrest in C. neoformans (T. Woyke, G. R. Pettit, G. Winkelmann, and R. K. Pettit, Antimicrob. Agents Chemother. 45:3580-3584, 2001), microtubule integrity and nuclear localization in auristatin PHE-treated cells were examined. Iterative deconvolution in conjunction with an optimized C. neoformans microtubule immunolabeling procedure enabled detailed visualization of the microtubule cytoskeleton in auristatin PHE-treated C. neoformans. The effect of auristatin PHE on C. neoformans microtubule organization was compared with that of the tubulin-binding agent nocodazole. Both drugs produced complete disruption first of cytoplasmic and then of spindle microtubules in a time-and concentrationdependent manner. Sub-MICs of auristatin PHE caused complete microtubule disruption within 4.5 h, while 1.5 times the nocodazole MIC was required for the same effect. For both drugs, disruption of microtubules was accompanied by blockage of nuclear migration and of nuclear and cellular division, resulting in cells arrested in a uninucleate, large-budded stage. Nocodazole and the linear peptide auristatin PHE are remarkably different in structure and spectrum of activity, yet on the cellular level, they have similar effects.The basidiomycetous budding yeast Cryptococcus neoformans was identified as a human pathogen more than 100 years ago (5). Due to the growing number of immunocompromised patients worldwide, the number of invasive infections caused by this encapsulated yeast has been increasing dramatically (6,15,29,42). The most frequent clinical manifestation of cryptococcal infection is meningoencephalitis, which is fatal if left untreated. Existing therapies, including polyene and azole antifungals (11,29,42,49), are limited by host toxicities (42) and the emergence of drug-resistant strains (18,20).The pentapeptide auristatin PHE (dovaline-valine-dolaisoleunine-dolaproine-phenylalanine-methyl-ester) is a synthetic modification of the natural marine product dolastatin 10 (37, 38), which is currently undergoing phase I and phase II cancer clinical trials. Auristatin PHE has fungicidal activity against C. neoformans and fungicidal or fungistatic activity against various species of Trichosporon (39, 50). Auristatin PHE caused C. neoformans cells to arrest in a large-budded stage (50), suggesting that it might interfere with the microtubule dynamics in a manner similar to that of nocodazole in Saccharomyces cerevisiae (17).To investigate this possibility, we optimized cell wall digestion and microtubule labeling conditions for C. neoformans. This procedure, in conjunction with iterative deconvolution microscopy, allowed detailed visualization of the C. neoformans microtubule network. In iterative deconvolution, the focal Z plane sections are digitally captured and out-of-focus light in each section is mathematically removed and/or reduced by examination of neighboring sections (2, 43). T...